SANGAMO THERAP.INC.DL-,01 financial statements, including revenue, expenses, profit, and loss

The total revenue of GBY for the last quarter is 1.85 M EUR, and it's 79.19% lower compared to the previous quarter. The net income of Q4 23 is -54.63 M EUR.